Market Research Logo

Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 – 2022

Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 – 2022

The global vaccines & vaccination market is expected to grow at the CAGR of 10.5% during 2016-2022. The market has generated revenue of more than $ 467 million in 2016 and is projected to reach up to $ $769.4 million by 2022. Due to rising use of adjuvants in vaccine-preventable diseases, increasing government investments and initiatives, rising company investments in vaccine development and increasing initiatives by non-government organizations become the major drivers which help to increase the market of vaccines & vaccination globally. Due to increasing prevalence of diseases such as HIV/AIDS, cancer and allergy, there is an increase in the demand of adjuvants vaccine. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. It is seen that more than 8% population is suffering from food allergy, globally, among which approximately 6% aged 0-2 years, 9% aged 3-5 years and nearly 8% aged 6-10 years, approximately 8% aged 11-13 years and more than 8.5% aged 14-18 years suffer from food allergy globally. The developing regions such as India, China has been on an uprising trend in terms of severity as well as prevalence of diseases. These allergic diseases contain asthma, rhinitis, anaphylaxis, drug, food and insect allergy and many more. Approx. 20% to 30 % of total population suffers from at least one of these allergic diseases in India among which 20% to 30% of the population suffers from allergic rhinitis and 15% have asthma.

On the basis of segmentation the market of vaccines & vaccination is segmented as technology, type, disease indication, and end user. On the basis of technology, the market of vaccines & vaccination is segmented as subunit vaccines, live attenuated vaccines, conjugate vaccines, inactivated vaccines, recombinant vector vaccines, toxoid vaccines, synthetic vaccines, dendritic cell vaccines. Based on types, the market is segmented into preventive vaccines and therapeutic vaccines. Similarly, based on end users the market is segmented as pediatrics and adults.

Geographically, the vaccines &vaccination market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market share of vaccines & vaccination followed by Europe and Asia Pacific. Due to governmental initiatives, and increasing focus of major players in the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI helps to increase the market of Asia Pacific region.

Some of the major market players are Abbott Astrazeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bio Med, CSL Limited , Emergent Biosolutions, Inc., Glaxosmithkline, PLC, Johnson & Johnson , Medimmune, LLC. (A Subsidiary Of Astrazeneca), Merck & Co., Inc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market. For example in 2014, Abbot diagnostic had acquired US based Topera Inc,. a venture backed with medical device company that focuses on electrophysiology technology for diagnosis and treatment of trial fibrillation.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC TECHNOLOGIES
2.3.1. RAW MATERIAL SUPPLIER
2.3.2. PRODUCTION GEOGRAPHICALLY
2.3.3. ADOPTION ACROSS VARIOUS INDUSTRIES
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. TOP 3 GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE TECHNOLOGIES
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING USE OF ADJUVANTS IN VACCINE-PREVENTABLE DISEASES
3.1.2. INCREASING GOVERNMENT INVESTMENTS AND INITIATIVES.
3.1.3. RISING COMPANY INVESTMENTS IN VACCINE DEVELOPMENT
3.1.4. INCREASING INITIATIVES BY NON-GOVERNMENT ORGANIZATIONS
3.2. MARKET RESTRAINTS
3.2.1. RISING COST OF RESEARCH
3.2.2. HIGH REGULATORY HURDLES
3.3. MARKET OPPORTUNITIES
3.3.1. COMBINED ADJUVANTS
3.3.2. VACCINES FOR YOUNG CHILDREN
3.3.3. WIDESPREAD OF DISEASES
3.3.4. INCREASING DEMAND IN EMERGING ECONOMIES
3.4. MARKET CHALLENGES
3.4.1. RECOGNITION OF ADJUVANTS
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET
4. MARKET SEGMENTATION
4.1. BY TECHNOLOGY
4.1.1. GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2022 ($ MILLION)
4.1.2. GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2022 ($ MILLION)
4.1.3. GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2022 ($ MILLION)
4.1.4. GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES 2014-2022 ($ MILLION)
4.1.5. GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES 2014-2022 ($ MILLION)
4.1.6. GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2022 ($ MILLION)
4.1.7. GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2022 ($ MILLION)
4.1.8. GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2022 ($ MILLION)
4.2. BY TYPE
4.2.1. GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2022 ($ MILLION)
4.2.2. GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2022 ($ MILLION)
4.3. BY DISEASE INDICATION
4.3.1. GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2022 ($ MILLION)
4.3.1.1. GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA
4.3.1.2. GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2022 ($ MILLION)
4.3.1.3. GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2022 ($ MILLION)
4.3.1.4. GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2022 ($ MILLION)
4.3.1.5. GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2022 ($ MILLION)
4.3.1.6. GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2022 ($ MILLION)
4.3.1.7. GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA 2014-2022 ($ MILLION)
4.3.1.8. GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2022 ($ MILLION)
4.3.1.9. GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2022 ($ MILLION)
4.3.1.10. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
4.3.2. GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2022 ($ MILLION)
4.3.2.1. GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER 2014-2022 ($ MILLION)
4.3.2.2. GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2022 ($ MILLION)
4.3.3. GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2022 ($ MILLION)
4.4. BY END USERS
4.4.1. GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2022 ($ MILLION)
4.4.2. GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2022 ($ MILLION)
5. GEOGRAPHICAL TECHNOLOGIES
5.1. NORTH AMERICA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.1.1. UNITED STATES (U.S.) VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.1.2. CANADA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2. EUROPE VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2.1. UNITED KINGDOM (UK) VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2.2. FRANCE VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2.3. GERMANY VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2.4. SPAIN VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2.5. ITALY VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.2.6. ROE VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3. ASIA PACIFIC VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3.1. INDIA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3.2. CHINA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3.3. JAPAN VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3.4. KOREA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3.5. AUSTRALIA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.3.6. ROAPAC VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.4. REST OF THE WORLD VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.4.1. LATIN AMERICA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.4.2. MENA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
5.4.3. AFRICA VACCINES & VACCINATION MARKET 2014-2022 ($ MILLION)
6. COMPANY PROFILES
ABBOTT
ASTRAZENECA
BAVARIAN NORDIC
BAXTER
BHARAT BIOTECH
BIO MED
CSL LIMITED
EMERGENT BIOSOLUTIONS, INC.
GLAXOSMITHKLINE, PLC
JOHNSON &JOHNSON
MEDIMMUNE, LLC. (A SUBSIDIARY OF ASTRAZENECA)
MERCK &CO., INC.
NOVARTIS AG
PFIZER, INC.
SANOFI
LIST OF TABLE
GLOBAL VACCINES & VACCINATION MARKET BY TECHNOLOGY ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY TYPE ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY DISEASE INDICATION $MILLION
GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY MMR ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY DTP ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY POLIO ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY OTHERS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY CANCER ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY OTHERS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY END USERS $MILLION
GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY ADULTS ($ MILLION)
LIST OF FIGURES
GLOBAL VACCINES & VACCINATION MARKET BY TECHNOLOGY ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES,($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY TYPE ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY DISEASE INDICATION $MILLION
GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY MMR ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY DTP ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY POLIO ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY OTHERS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY CANCER ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY OTHERS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY END USERS $MILLION
GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS ($ MILLION)
GLOBAL VACCINES & VACCINATION MARKET BY ADULTS ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report